1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Somatic Cell Gene Therapy (SCGT) 1.4.3 Germline Gene Therapy (GGT) 1.5 Market by Application 1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026 1.5.2 Cancer Research Centers 1.5.3 Diagnostic Laboratories 1.5.4 Cancer Hospitals 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Cancer Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Gene Therapies for Cancer Treatment Industry 1.6.1.1 Gene Therapies for Cancer Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Gene Therapies for Cancer Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Gene Therapies for Cancer Treatment Market Perspective (2015-2026) 2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions 2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gene Therapies for Cancer Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Gene Therapies for Cancer Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gene Therapies for Cancer Treatment Players by Market Size 3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2015-2020) 3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gene Therapies for Cancer Treatment Market Concentration Ratio 3.2.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2019 3.3 Gene Therapies for Cancer Treatment Key Players Head office and Area Served 3.4 Key Players Gene Therapies for Cancer Treatment Product Solution and Service 3.5 Date of Enter into Gene Therapies for Cancer Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2015-2020) 4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2021-2026) 5 Gene Therapies for Cancer Treatment Breakdown Data by Application (2015-2026) 5.1 Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gene Therapies for Cancer Treatment Market Size (2015-2020) 6.2 Gene Therapies for Cancer Treatment Key Players in North America (2019-2020) 6.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 6.4 North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gene Therapies for Cancer Treatment Market Size (2015-2020) 7.2 Gene Therapies for Cancer Treatment Key Players in Europe (2019-2020) 7.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 7.4 Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 8 China 8.1 China Gene Therapies for Cancer Treatment Market Size (2015-2020) 8.2 Gene Therapies for Cancer Treatment Key Players in China (2019-2020) 8.3 China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 8.4 China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Gene Therapies for Cancer Treatment Market Size (2015-2020) 9.2 Gene Therapies for Cancer Treatment Key Players in Japan (2019-2020) 9.3 Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 9.4 Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2015-2020) 10.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 11 India 11.1 India Gene Therapies for Cancer Treatment Market Size (2015-2020) 11.2 Gene Therapies for Cancer Treatment Key Players in India (2019-2020) 11.3 India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 11.4 India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2015-2020) 12.2 Gene Therapies for Cancer Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) 12.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Takara Bio 13.1.1 Takara Bio Company Details 13.1.2 Takara Bio Business Overview and Its Total Revenue 13.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction 13.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)) 13.1.5 Takara Bio Recent Development 13.2 Tocagen 13.2.1 Tocagen Company Details 13.2.2 Tocagen Business Overview and Its Total Revenue 13.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction 13.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.2.5 Tocagen Recent Development 13.3 VBL Therapeutics 13.3.1 VBL Therapeutics Company Details 13.3.2 VBL Therapeutics Business Overview and Its Total Revenue 13.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction 13.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.3.5 VBL Therapeutics Recent Development 13.4 Cold Genesys 13.4.1 Cold Genesys Company Details 13.4.2 Cold Genesys Business Overview and Its Total Revenue 13.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction 13.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.4.5 Cold Genesys Recent Development 13.5 Genprex 13.5.1 Genprex Company Details 13.5.2 Genprex Business Overview and Its Total Revenue 13.5.3 Genprex Gene Therapies for Cancer Treatment Introduction 13.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.5.5 Genprex Recent Development 13.6 Momotaro-Gene 13.6.1 Momotaro-Gene Company Details 13.6.2 Momotaro-Gene Business Overview and Its Total Revenue 13.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction 13.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.6.5 Momotaro-Gene Recent Development 13.7 MultiVir 13.7.1 MultiVir Company Details 13.7.2 MultiVir Business Overview and Its Total Revenue 13.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction 13.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.7.5 MultiVir Recent Development 13.8 SynerGene Therapeutics 13.8.1 SynerGene Therapeutics Company Details 13.8.2 SynerGene Therapeutics Business Overview and Its Total Revenue 13.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction 13.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.8.5 SynerGene Therapeutics Recent Development 13.9 Ziopharm Oncology 13.9.1 Ziopharm Oncology Company Details 13.9.2 Ziopharm Oncology Business Overview and Its Total Revenue 13.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction 13.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.9.5 Ziopharm Oncology Recent Development 13.10 Anchiano Therapeutics 13.10.1 Anchiano Therapeutics Company Details 13.10.2 Anchiano Therapeutics Business Overview and Its Total Revenue 13.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction 13.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 13.10.5 Anchiano Therapeutics Recent Development 13.11 Celgene 10.11.1 Celgene Company Details 10.11.2 Celgene Business Overview and Its Total Revenue 10.11.3 Celgene Gene Therapies for Cancer Treatment Introduction 10.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 10.11.5 Celgene Recent Development 13.12 Celsion 10.12.1 Celsion Company Details 10.12.2 Celsion Business Overview and Its Total Revenue 10.12.3 Celsion Gene Therapies for Cancer Treatment Introduction 10.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 10.12.5 Celsion Recent Development 13.13 Bluebird Bio 10.13.1 Bluebird Bio Company Details 10.13.2 Bluebird Bio Business Overview and Its Total Revenue 10.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction 10.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) 10.13.5 Bluebird Bio Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Gene Therapies for Cancer Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue Table 3. Ranking of Global Top Gene Therapies for Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Somatic Cell Gene Therapy (SCGT) Table 6. Key Players of Germline Gene Therapy (GGT) Table 7. COVID-19 Impact Global Market: (Four Gene Therapies for Cancer Treatment Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Gene Therapies for Cancer Treatment Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact Table 12. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Gene Therapies for Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Gene Therapies for Cancer Treatment Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Gene Therapies for Cancer Treatment Market Share by Regions (2015-2020) Table 16. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Gene Therapies for Cancer Treatment Market Growth Strategy Table 22. Main Points Interviewed from Key Gene Therapies for Cancer Treatment Players Table 23. Global Gene Therapies for Cancer Treatment Revenue by Players (2015-2020) (Million US$) Table 24. Global Gene Therapies for Cancer Treatment Market Share by Players (2015-2020) Table 25. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019) Table 26. Global Gene Therapies for Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Gene Therapies for Cancer Treatment Product Solution and Service Table 29. Date of Enter into Gene Therapies for Cancer Treatment Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 32. Global Gene Therapies for Cancer Treatment Market Size Share by Type (2015-2020) Table 33. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2021-2026) Table 34. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2015-2020) Table 35. Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 36. Global Gene Therapies for Cancer Treatment Market Size Share by Application (2021-2026) Table 37. North America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 38. North America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 39. North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 40. North America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 41. North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 42. North America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 43. Europe Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 45. Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 46. Europe Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 47. Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 48. Europe Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 49. China Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 50. China Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 51. China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 52. China Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 53. China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 54. China Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 55. Japan Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 57. Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 58. Japan Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 59. Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 60. Japan Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 63. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 65. Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 67. India Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 68. India Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 69. India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 70. India Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 71. India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 72. India Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 73. Central & South America Key Players Gene Therapies for Cancer Treatment Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Gene Therapies for Cancer Treatment Market Share (2019-2020) Table 75. Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Gene Therapies for Cancer Treatment Market Share by Type (2015-2020) Table 77. Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Gene Therapies for Cancer Treatment Market Share by Application (2015-2020) Table 79. Takara Bio Company Details Table 80. Takara Bio Business Overview Table 81. Takara Bio Product Table 82. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 83. Takara Bio Recent Development Table 84. Tocagen Company Details Table 85. Tocagen Business Overview Table 86. Tocagen Product Table 87. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 88. Tocagen Recent Development Table 89. VBL Therapeutics Company Details Table 90. VBL Therapeutics Business Overview Table 91. VBL Therapeutics Product Table 92. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 93. VBL Therapeutics Recent Development Table 94. Cold Genesys Company Details Table 95. Cold Genesys Business Overview Table 96. Cold Genesys Product Table 97. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 98. Cold Genesys Recent Development Table 99. Genprex Company Details Table 100. Genprex Business Overview Table 101. Genprex Product Table 102. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 103. Genprex Recent Development Table 104. Momotaro-Gene Company Details Table 105. Momotaro-Gene Business Overview Table 106. Momotaro-Gene Product Table 107. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 108. Momotaro-Gene Recent Development Table 109. MultiVir Company Details Table 110. MultiVir Business Overview Table 111. MultiVir Product Table 112. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 113. MultiVir Recent Development Table 114. SynerGene Therapeutics Business Overview Table 115. SynerGene Therapeutics Product Table 116. SynerGene Therapeutics Company Details Table 117. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 118. SynerGene Therapeutics Recent Development Table 119. Ziopharm Oncology Company Details Table 120. Ziopharm Oncology Business Overview Table 121. Ziopharm Oncology Product Table 122. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 123. Ziopharm Oncology Recent Development Table 124. Anchiano Therapeutics Company Details Table 125. Anchiano Therapeutics Business Overview Table 126. Anchiano Therapeutics Product Table 127. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 128. Anchiano Therapeutics Recent Development Table 129. Celgene Company Details Table 130. Celgene Business Overview Table 131. Celgene Product Table 132. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 133. Celgene Recent Development Table 134. Celsion Company Details Table 135. Celsion Business Overview Table 136. Celsion Product Table 137. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 138. Celsion Recent Development Table 139. Bluebird Bio Company Details Table 140. Bluebird Bio Business Overview Table 141. Bluebird Bio Product Table 142. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020) (Million US$) Table 143. Bluebird Bio Recent Development Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapies for Cancer Treatment Market Share by Type: 2020 VS 2026 Figure 2. Somatic Cell Gene Therapy (SCGT) Features Figure 3. Germline Gene Therapy (GGT) Features Figure 4. Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026 Figure 5. Cancer Research Centers Case Studies Figure 6. Diagnostic Laboratories Case Studies Figure 7. Cancer Hospitals Case Studies Figure 8. Others Case Studies Figure 9. Gene Therapies for Cancer Treatment Report Years Considered Figure 10. Global Gene Therapies for Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Gene Therapies for Cancer Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Gene Therapies for Cancer Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Gene Therapies for Cancer Treatment Market Share by Players in 2019 Figure 15. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapies for Cancer Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2019 Figure 17. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Gene Therapies for Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 26. Tocagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 28. VBL Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 30. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 32. Genprex Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 34. Momotaro-Gene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 36. MultiVir Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 38. SynerGene Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 40. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 42. Anchiano Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 44. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 46. Celsion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 48. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Takara Bio Tocagen VBL Therapeutics Cold Genesys Genprex Momotaro-Gene MultiVir SynerGene Therapeutics Ziopharm Oncology Anchiano Therapeutics Celgene Celsion Bluebird Bio